New Scientist4h
Twin spacecraft will launch to create an artificial solar eclipse
The Proba-3 mission consists of two spacecraft that will fly in close formation to study the sun, with the shadow of one ...
Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial
Immutep's INSIGHT-003 Phase 1 trial reports promising survival data for 1L NSCLC treatment using eftilagimod alpha, Keytruda, ...
Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer
Media ReleaseMature data in patients with a minimum follow-up of 22 months (N=21) shows excellent results, well above historical controls and ...
New “3-in-1” Antibody Shows Promise for Faster, Safer Cancer Therapy
Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, ...
emjreviews.com12h
Three-Cycle Chemotherapy Proves Effective for High-Risk Retinoblastoma
A new study shows that 3 cycles of CEV chemotherapy provide noninferior 5-year disease-free survival compared to 6 cycles in ...
On3 writer predicts Ole Miss flips four-star from LSU
Signing day is less than a month away and programs are making a final push to flip the nation's top recruits. LSU may wind up being on the wrong end of flip season per a recent prediction from On3's ...